|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vincent A, Herman J, Schulick R, Hruban RH
and Goggins M: Pancreatic cancer. Lancet. 378:607–620. 2011.
View Article : Google Scholar
|
|
3
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer statistics, 2011: the impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel DH, Ashton GH, Penagos HG, et al:
Loss of kindlin-1, a human homolog of the Caenorhabditis
elegans actin-extracellular-matrix linker protein UNC-112,
causes Kindler syndrome. Am J Hum Genet. 73:174–187. 2003.
|
|
5
|
Jobard F, Bouadjar B, Caux F, et al:
Identification of mutations in a new gene encoding a FERM family
protein with a pleckstrin homology domain in Kindler syndrome. Hum
Mol Genet. 12:925–935. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ussar S, Moser M, Widmaier M, et al: Loss
of Kindlin-1 causes skin atrophy and lethal neonatal intestinal
epithelial dysfunction. PLoS Genet. 4:e10002892008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kloeker S, Major MB, Calderwood DA,
Ginsberg MH, Jones DA and Beckerle MC: The Kindler syndrome protein
is regulated by transforming growth factor-beta and involved in
integrin-mediated adhesion. J Biol Chem. 279:6824–6833. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ussar S, Wang HV, Linder S, Fassler R and
Moser M: The Kindlins: subcellular localization and expression
during murine development. Exp Cell Res. 312:3142–3151. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cabodi S, del Pilar Camacho-Leal M, Di
Stefano P and Defilippi P: Integrin signalling adaptors: not only
figurants in the cancer story. Nat Rev Cancer. 10:858–870. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Moser M, Legate KR, Zent R and Fassler R:
The tail of integrins, talin, and kindlins. Science. 324:895–899.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Harburger DS, Bouaouina M and Calderwood
DA: Kindlin-1 and -2 directly bind the C-terminal region of beta
integrin cytoplasmic tails and exert integrin-specific activation
effects. J Biol Chem. 284:11485–11497. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Plow EF, Qin J and Byzova T: Kindling the
flame of integrin activation and function with kindlins. Curr Opin
Hematol. 16:323–328. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Goult BT, Bouaouina M, Harburger DS, et
al: The structure of the N-terminus of kindlin-1: a domain
important for alphaiib-beta3 integrin activation. J Mol Biol.
394:944–956. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kuijpers TW, van de Vijver E, Weterman MA,
et al: LAD-1/variant syndrome is caused by mutations in FERMT3.
Blood. 113:4740–4746. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Has C, Herz C, Zimina E, et al: Kindlin-1
is required for RhoGTPase-mediated lamellipodia formation in
keratinocytes. Am J Pathol. 175:1442–1452. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Montanez E, Ussar S, Schifferer M, et al:
Kindlin-2 controls bidirectional signaling of integrins. Genes Dev.
22:1325–1330. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Weinstein EJ, Bourner M, Head R, Zakeri H,
Bauer C and Mazzarella R: URP1: a member of a novel family of PH
and FERM domain-containing membrane-associated proteins is
significantly over-expressed in lung and colon carcinomas. Biochim
Biophys Acta. 1637:207–216. 2003. View Article : Google Scholar
|
|
18
|
Sin S, Bonin F, Petit V, et al: Role of
the focal adhesion protein kindlin-1 in breast cancer growth and
lung metastasis. J Natl Cancer Inst. 103:1323–1337. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ohuchida K, Mizumoto K, Murakami M, et al:
Radiation to stromal fibroblasts increases invasiveness of
pancreatic cancer cells through tumor-stromal interactions. Cancer
Res. 64:3215–3222. 2004. View Article : Google Scholar
|
|
20
|
Zhang L, Mizumoto K, Sato N, et al:
Quantitative determination of apoptotic death in cultured human
pancreatic cancer cells by propidium iodide and digitonin. Cancer
Lett. 142:129–137. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Papachristou DJ, Gkretsi V, Tu Y, et al:
Increased cytoplasmic level of migfilin is associated with higher
grades of human leiomyosarcoma. Histopathology. 51:499–508. 2007.
View Article : Google Scholar
|
|
22
|
Harburger DS and Calderwood DA: Integrin
signalling at a glance. J Cell Sci. 122:159–163. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ye F and Petrich BG: Kindlin: helper,
co-activator, or booster of talin in integrin activation? Curr Opin
Hematol. 18:356–360. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Arao S, Masumoto A and Otsuki M: Beta1
integrins play an essential role in adhesion and invasion of
pancreatic carcinoma cells. Pancreas. 20:129–137. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Iwatsuki M, Mimori K, Yokobori T, et al:
Epithelialmesenchymal transition in cancer development and its
clinical significance. Cancer Sci. 101:293–299. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rane SG, Lee JH and Lin HM: Transforming
growth factor-beta pathway: role in pancreas development and
pancreatic disease. Cytokine Growth Factor Rev. 17:107–119. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bierie B and Moses HL: TGF-beta and
cancer. Cytokine Growth Factor Rev. 17:29–40. 2006. View Article : Google Scholar
|
